These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23541984)

  • 21. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen.
    Vergote GJ; Vervaet C; Van Driessche I; Hoste S; De Smedt S; Demeester J; Jain RA; Ruddy S; Remon JP
    Int J Pharm; 2002 Jun; 240(1-2):79-84. PubMed ID: 12062503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.
    Hodges LA; Connolly SM; Band J; O'Mahony B; Ugurlu T; Turkoglu M; Wilson CG; Stevens HN
    Int J Pharm; 2009 Mar; 370(1-2):144-50. PubMed ID: 19114096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
    Sarfraz MK; Rehman NU; Mohsin S
    Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
    Someshwar K; Chithaluru K; Ramarao T; Kumar KK
    Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective drug release from ketoprofen and ricobendazole matrix tablets.
    Alvarez C; Torrado JJ; Cadórniga R
    Chirality; 1999; 11(8):611-5. PubMed ID: 10467311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spray-dried microspheres containing ketoprofen formulated into capsules and tablets.
    Moretti MD; Gavini E; Juliano C; Pirisino G; Giunchedi P
    J Microencapsul; 2001; 18(1):111-21. PubMed ID: 11201334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new approach for preparing a controlled release ketoprofen tablets by using beeswax.
    Uner M; Gönüllü U; Yener G; Altinkurt T
    Farmaco; 2005 Jan; 60(1):27-31. PubMed ID: 15652365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.
    Hodges LA; Sime KA; Creech LA; Connolly SM; Barclay ST; Kwon MC; Jeon BJ; Shim SM; Wang HS; Stevens HN; Park JS
    Int J Pharm; 2013 Sep; 454(1):41-6. PubMed ID: 23834829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ex vivo mucoadhesion and in vivo bioavailability assessment and correlation of ketoprofen tablet dosage forms containing bioadhesives.
    Zaghloul A; Taha E; Afouna M; Khattab I; Nazzal S
    Pharmazie; 2007 May; 62(5):346-50. PubMed ID: 17557741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
    van der Weerd J; Kazarian SG
    J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and optimization of intermediate release ketoprofen tablets by central composite design.
    Zafar F; Shoaib MH; Yousuf RI; Ali H; Bushra R
    Pak J Pharm Sci; 2018 Sep; 31(5):1827-1836. PubMed ID: 30150177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
    Pan J; Lu W; Li C; Wang S; He L
    Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
    Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
    Sinha VR; Mittal BR; Kumria R
    Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of salbutamol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives.
    Solinís MA; de la Cruz Y; Calvo B; Hernández RM; Gascón AR; Goñi I; Gurruchaga MD; Pedraz JL
    Chirality; 2002 Nov; 14(10):806-13. PubMed ID: 12395398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.